COVID-19 VAX Booster Dosing in Patients With Hematologic Malignancies
Condition(s):Multiple Myeloma; AL Amyloidosis; Chronic Lymphocytic LeukemiaLast Updated:December 20, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Multiple Myeloma; AL Amyloidosis; Chronic Lymphocytic LeukemiaLast Updated:December 20, 2023Completed
Condition(s):COVIDLast Updated:May 13, 2022Completed
Condition(s):COVID-19Last Updated:March 24, 2021Completed
Condition(s):Anti-SARS-CoV-2 Antibody ResponseLast Updated:January 11, 2023Terminated
Condition(s):Multiple Sclerosis; Demyelinating Autoimmune Diseases, CNS; Autoimmune Diseases of the Nervous System; Nervous System Diseases; Demyelinating Diseases; Autoimmune Diseases; Immune System Diseases; Pathologic ProcessesLast Updated:August 2, 2021Completed
Condition(s):COVID-19; SARS-CoV 2; Health PersonnelLast Updated:May 28, 2020Unknown status
Condition(s):Coronavirus Infection; Severe Acute Respiratory SyndromeLast Updated:December 28, 2023Active, not recruiting
Condition(s):Coronavirus InfectionLast Updated:February 3, 2021Completed
Condition(s):COVID-19Last Updated:March 2, 2022Unknown status
Condition(s):COVID-19; SARS-CoV 2Last Updated:June 12, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.